Therapeutic Devices for Motor Symptoms in Parkinson’s Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials

Abstract

BackgroundPharmacotherapy is the first-line treatment option for Parkinson’s disease, and levodopa is considered the most effective drug for managing motor symptoms. However, side effects such as motor fluctuation and dyskinesia have been associated with levodopa treatment. For these conditions, alternative therapies, including invasive and non-invasive medical devices, may be helpful. This review sheds light on current progress in the development of devices to alleviate motor symptoms in Parkinson’s disease.MethodsWe first conducted a narrative literature review to obtain an overview of current invasive and non-invasive medical devices and thereafter performed a systematic review of recent randomized controlled trials (RCTs) of these devices.ResultsOur review revealed different characteristics of each device and their effectiveness for motor symptoms. Although invasive medical devices are usually highly effective, surgical procedures can be burdensome for patients and have serious side effects. In contrast, non-pharmacological/non-surgical devices have fewer complications. RCTs of non-invasive devices, especially non-invasive brain stimulation and mechanical peripheral stimulation devices, have proven effectiveness on motor symptoms. Nearly no non-invasive devices have yet received Food and Drug Administration certification or a CE mark.ConclusionInvasive and non-invasive medical devices have unique characteristics, and several RCTs have been conducted for each device. Invasive devices are more effective, while non-invasive devices are less effective and have lower hurdles and risks. It is important to understand the characteristics of each device and capitalize on these.

A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study

“…Parkinson's disease has a complex neuropathology, with much patient heterogeneity due to the progressive loss of dopaminergic neurons in the substantia nigra, producing the classic changes in motor function including bradykinesia, tremor, rigidity, and postural instability that invariably progress over time. 1 While there are several treatment options available to manage the motor signs and symptoms of Parkinson's disease, including pharmaceutical options such as dopamine replacement and dopamine agonists as well as therapeutic devices, such as deep brain stimulation and non-invasive devices, 2 treatment remains a challenge with further options needed. 3 …”

Cranial geometry in patients with dystonia and Parkinson’s disease

“…To the best of our knowledge, no studies have investigated this possibility in neurodegenerative disorders such as dystonia and PD. Deep brain stimulation (DBS) is often used for treating dystonia and PD 8 . Understanding the cranial geometry is important when performing DBS surgery, where electrodes are precisely inserted at microscopic targets in the deep brain such as the subthalamic nucleus and ventral intermediate nucleus.…”

Diagnosis and Treatment of Tremor in Parkinson’s Disease Using Mechanical Devices

“…Researchers are investigating techniques for tremor detection based on data acquired from inertial sensors and other sources [ 32 , 33 ], which is essential to avoid the risk of suppressing non-tremor movement. Treatment using mechanical devices in patients with PD has been reported to be effective and is widely accepted [ 34 ]. In this systematic narrative literature review, we will introduce recent technologies and research trends related to PD tremor diagnosis using devices, device-based tremor treatment, and orthosis for tremor control ( Figure 1 ).…”